Daniel Harrison What do we know about different diets and how they relate to cancer? Ever questioned what the evidence supports? Chadi is joined by Urvi Shah, MD, a myeloma expert and cancer survivor, and Neil Lyengar, MD, a medical oncologist, from Memorial Sloan Kettering Cancer Center to address this crucial question (breast cancer expert). They discuss the methodologies for examining these relationships in the breast and myeloma spaces, lifestyle and dietary interventions they are studying, how Keto and plant-based diets factor into the conversation, and much more. They also discuss whether there is a direct cause-and-effect relationship between lack of exercise and cancer diagnoses and alcohol/food consumption and cancer diagnoses.
Concerning Healthcare Unfiltered
Healthcare Unfiltered is an open, unvarnished podcast that covers all healthcare-related issues that concern stakeholders. Dr. Chadi Nabhan challenges his guests to discuss contentious and significant issues using his engaging conversational skills. He also invites well-known experts from around the world to speak about recent medical developments.
Also Read :Three healthcare data security risks to be aware of in 2023
Malignant haematology and GU malignancies are two of Dr. Nabhan’s areas of expertise as a haematologist and medical oncologist. Before finishing his residency at Loyola University in Chicago and a fellowship at Northwestern University and the Robert H. Lurie Comprehensive Cancer Center, he spent two years conducting basic science research at Massachusetts General Hospital/Harvard Medical School. He graduated from Loyola University Quinlan School of Business with an MBA in Health Care Management.
Dr. Nabhan has extensive experience in all healthcare settings, having worked at prestigious academic institutions, sizable community hospitals, and start-up businesses as well as Fortune 14 companies, holding C suite level positions in progressive leadership positions. Academically, Chadi has over 300 peer-reviewed original articles, abstracts, or book chapters to his credit. He also sits on the editorial board of JAMA-Oncology. Chadi has served as the principal investigator on numerous clinical trials (investor-initiated, cooperative groups, and pharma-sponsored).
